RhythmAnalytics vs qXR-CTR
AI Verdict
Choose RhythmAnalytics if…
Choose RhythmAnalytics if your primary need is automated, AI-powered interpretation of single-lead ECG data for precise detection and classification of various cardiac arrhythmias. This tool is ideal for healthcare providers seeking to integrate advanced ECG analysis capabilities with existing FDA-cleared ECG devices, providing enhanced clinical decision support for rhythm disorders.
View RhythmAnalytics →Choose qXR-CTR if…
Choose qXR-CTR if your focus is on efficiently assessing heart size and potential heart failure risk directly from chest X-ray images. This AI-powered solution is best suited for radiology and emergency departments that require automated, accurate measurement of the cardiothoracic ratio to aid in initial screening and risk stratification.
View qXR-CTR →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | RhythmAnalytics | qXR-CTR |
|---|---|---|
| Pricing | Contact vendor | Unknown |
| Deployment | Cloud-based API | Can be deployed on cloud or on-premise. The Qure.ai app receives DICOM studies via DICOM network protocol from medical systems (PACS/Modality) or can import DICOM from the local system. The received DICOM study is processed in Qure's cloud server, and AI-processed reports are displayed on the app. |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
qXR-CTRTool B (qXR-CTR) offers multiple deployment options (cloud, on-premise, hybrid) and provides an app for on-cloud image viewing with pre-read assistance and visual overlays, suggesting a more direct and integrated user experience for clinicians. Tool A (RhythmAnalytics) is primarily a cloud-based API, implying that its direct usability depends on the user interface built by integrators rather than a standalone application.
Clinical Value
RhythmAnalyticsBoth tools are FDA-cleared and clinically validated. However, Tool A (RhythmAnalytics) provides automated interpretation and detection of over 15 types of cardiac arrhythmias from single-lead ECG data, offering broad and immediate clinical decision support for critical conditions. Tool B (qXR-CTR) automates a specific measurement (cardiothoracic ratio) that aids in assessing heart size and potential heart failure risk, which is valuable but more focused on a single metric.
Pricing & Value
qXR-CTRWhile both tools require contacting the vendor for specific pricing, Tool B (qXR-CTR), as part of the broader qXR platform, has some public information indicating a 'pay-per-use' or 'subscription' model with studies suggesting cost-effectiveness and potential cost-neutrality in certain scenarios. Tool A (RhythmAnalytics) only mentions being offered as 'Software-as-a-Service' without further details on its pricing structure or value proposition.
Enterprise Readiness
qXR-CTRTool B (qXR-CTR) explicitly states it has a Business Associate Agreement (BAA) and offers flexible deployment options including cloud, on-premise, and hybrid. Additionally, Qure.ai (Tool B's company) is ISO 27001 certified, GDPR-compliant, and integrates with numerous major PACS vendors, demonstrating a higher level of enterprise readiness and security commitment. Tool A's BAA status is unspecified, and its deployment is limited to a cloud-based API.
Innovation
RhythmAnalyticsBoth tools leverage AI for innovation in their respective domains. However, Tool A (RhythmAnalytics) demonstrates a more complex and impactful AI application by providing automated interpretation of over 15 distinct cardiac arrhythmias from single-lead ECG data, addressing a critical need for comprehensive diagnostic aid in remote monitoring and wearables. While Tool B automates a crucial measurement, the breadth and direct diagnostic nature of Tool A's interpretation represent a higher degree of AI sophistication for clinical decision support.
Support & Docs
qXR-CTRTool B (qXR-CTR) provides clear information about its comprehensive support structure, including dedicated client success partners, 24/7 support, personalized onboarding, ongoing education, and readily available user manuals and API documentation. In contrast, no specific information regarding support or documentation for Tool A (RhythmAnalytics) was found in the provided facts or search results.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | RhythmAnalytics | qXR-CTR |
|---|---|---|
| Name | RhythmAnalytics | qXR-CTR |
| Company | Biofourmis Singapore Pte. | Qure.ai Technologies |
| Description | FDA-cleared, AI-powered cloud-based software that provides automated interpretation of cardiac arrhythmias from single-lead ECG data, offering clinical decision support for healthcare professionals and integrators. | AI-powered software by Qure.ai that automates the measurement of the cardiothoracic ratio (CTR) from chest X-ray images, aiding in the assessment of heart size and potential heart failure risk. |
| Key Functionality | AI-based automated interpretation of cardiac arrhythmias; Detection of over 15 types of cardiac arrhythmias; Beat-by-beat morphology computation; ECG signal processing and analysis; QRS and Ventricular Ectopic Beat detection; QRS feature extraction, interval measurement, heart rate measurement, and rhythm analysis. | Automates the measurement of the cardiothoracic ratio (CTR) from chest X-ray images. |
| Specialties | Cardiology, Emergency Medicine, Internal Medicine | Cardiology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring RhythmAnalytics and qXR-CTR.